TABLE 1 from A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid TumorsBenjamin Garmezy,Mitesh J. Borad,Rastilav Bahleda,Cesar A. Perez,Li-Tzong Chen,Shumei Kato,Do-Youn Oh,Paul Severson,Betty Y. Tam,Cheng S. Quah,James J. Hardingcrossref（2024）引用 0|浏览8AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
